Chemopreventive evaluation of Tephrosia purpurea against N-nitrosodiethylamine-induced hepatocarcinogenesis in Wistar rats. 2012

Talib Hussain, and Hefazat H Siddiqui, and Sheeba Fareed, and Madhavan Vijayakumar, and Chandana Venkateswara Rao
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Integral University Pharmacognosy and Ethnopharmacology Division, National Botanical Research Institute, Lucknow, India.

OBJECTIVE The chemopreventive potential of Tephrosia purpurea extract (TPE) on N-nitrosodiethylamine (NDEA)-induced hepatocellular carcinoma (HCC) in Wistar rats was assessed. METHODS HCC was induced by a single intraperitoneal injection of NDEA (200 mg/kg) followed by subcutaneous injections of CCl(4) (3 ml/kg per week) for six weeks. After administration of the carcinogen, 200 and 400 mg/kg TPE were administered orally once a day throughout the study. RESULTS The levels of liver cancer markers, including α-fetoprotein and carcinoembryonic antigen, were substantially increased by NDEA treatment. TPE treatment significantly reduced liver injury and restored the entire liver cancer markers. Additionally, TPE markedly normalized the activity of antioxidant enzymes, namely lipid peroxidation, reduced glutathione, catalase, superoxide dismutase, glutathione peroxidase and glutathione-S-transferase in the liver of NDEA-treated rats. Treatment with TPE significantly reduced the nodule incidence and multiplicity in the carcinogen-bearing rats. Histological observations of the liver tissues correlated with the biochemical observations. CONCLUSIONS These findings powerfully support that T. purpurea prevented lipid peroxidation, suppressed the tumour burden, and promoted enzymatic and nonenzymatic antioxidant defence systems during NDEA-induced hepatocarcinogenesis. This might have been due to modulating the antioxidant defence status, which contributed to its anticarcinogenic potential.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008517 Phytotherapy Use of plants or herbs to treat diseases or to alleviate pain. Herb Therapy,Herbal Therapy
D010936 Plant Extracts Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. Herbal Medicines,Plant Extract,Extract, Plant,Extracts, Plant,Medicines, Herbal
D002251 Carbon Tetrachloride A solvent for oils, fats, lacquers, varnishes, rubber waxes, and resins, and a starting material in the manufacturing of organic compounds. Poisoning by inhalation, ingestion or skin absorption is possible and may be fatal. (Merck Index, 11th ed) Tetrachloromethane,Tetrachloride, Carbon
D002272 Carcinoembryonic Antigen A glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment. Antigens, CD66e,CD66e Antigen,Antigen, CD66e,Antigen, Carcinoembryonic,CD66e Antigens
D004052 Diethylnitrosamine A nitrosamine derivative with alkylating, carcinogenic, and mutagenic properties. Nitrosodiethylamine,N-Nitrosodiethylamine,N Nitrosodiethylamine
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D000509 alpha-Fetoproteins The first alpha-globulins to appear in mammalian sera during FETAL DEVELOPMENT and the dominant serum proteins in early embryonic life. alpha-Fetoprotein,alpha Fetoprotein,alpha Fetoproteins
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Talib Hussain, and Hefazat H Siddiqui, and Sheeba Fareed, and Madhavan Vijayakumar, and Chandana Venkateswara Rao
September 2005, Fitoterapia,
Talib Hussain, and Hefazat H Siddiqui, and Sheeba Fareed, and Madhavan Vijayakumar, and Chandana Venkateswara Rao
May 2010, Journal of cancer research and clinical oncology,
Talib Hussain, and Hefazat H Siddiqui, and Sheeba Fareed, and Madhavan Vijayakumar, and Chandana Venkateswara Rao
December 2001, Cell biochemistry and function,
Talib Hussain, and Hefazat H Siddiqui, and Sheeba Fareed, and Madhavan Vijayakumar, and Chandana Venkateswara Rao
October 2006, Fundamental & clinical pharmacology,
Talib Hussain, and Hefazat H Siddiqui, and Sheeba Fareed, and Madhavan Vijayakumar, and Chandana Venkateswara Rao
January 2014, Indian journal of pharmacology,
Talib Hussain, and Hefazat H Siddiqui, and Sheeba Fareed, and Madhavan Vijayakumar, and Chandana Venkateswara Rao
May 2013, Toxicology international,
Talib Hussain, and Hefazat H Siddiqui, and Sheeba Fareed, and Madhavan Vijayakumar, and Chandana Venkateswara Rao
June 2006, Chemico-biological interactions,
Talib Hussain, and Hefazat H Siddiqui, and Sheeba Fareed, and Madhavan Vijayakumar, and Chandana Venkateswara Rao
March 2007, Experimental oncology,
Talib Hussain, and Hefazat H Siddiqui, and Sheeba Fareed, and Madhavan Vijayakumar, and Chandana Venkateswara Rao
December 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Talib Hussain, and Hefazat H Siddiqui, and Sheeba Fareed, and Madhavan Vijayakumar, and Chandana Venkateswara Rao
June 2001, Pharmacology & toxicology,
Copied contents to your clipboard!